Chung K Y, Kang D S
Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 1999 Oct;40(5):490-5. doi: 10.3349/ymj.1999.40.5.490.
Sclerosis is a disease process in which idiopathic hardening occurs in the skin and/or internal organs as a result of the accumulation of type I collagen, induced mainly by transforming growth factor-beta. Colchicine and D-penicillamine are widely used for its treatment. Their effects are known to be due to post-translational down-regulation of type I collagen synthesis, with colchicine also up-regulating interstitial collagenase. To determine whether or not they have any pre-translational effect on type I collagen and MMP-1, and also to observe their effects on the action of TGF-beta, cultured neonatal foreskin fibroblasts were treated with colchicine and D-penicillamine, singly and together. The amount of type I collagen and MMP-1 mRNA were quantitated by Northern blot hybridization. Colchicine suppresses the basal level of type I collagen mRNA but minimally stimulates the mRNA expression of MMP-1, whereas D-penicillamine does not have any significant effects on either. Colchicine was also able to significantly suppress the TGF-beta-induced up-regulation of type I collagen mRNA expression.
硬化症是一种疾病过程,其中由于I型胶原蛋白的积累,在皮肤和/或内部器官中发生特发性硬化,主要由转化生长因子-β诱导。秋水仙碱和D-青霉胺被广泛用于其治疗。已知它们的作用是由于I型胶原蛋白合成的翻译后下调,秋水仙碱还上调间质胶原酶。为了确定它们是否对I型胶原蛋白和MMP-1有任何翻译前作用,以及观察它们对TGF-β作用的影响,将培养的新生儿包皮成纤维细胞单独或一起用秋水仙碱和D-青霉胺处理。通过Northern印迹杂交定量I型胶原蛋白和MMP-1 mRNA的量。秋水仙碱抑制I型胶原蛋白mRNA的基础水平,但对MMP-1的mRNA表达刺激最小,而D-青霉胺对两者均无任何显著影响。秋水仙碱也能够显著抑制TGF-β诱导的I型胶原蛋白mRNA表达上调。